Published in Eur J Cardiothorac Surg on October 16, 2010
Intensive care unit and lung cancer: when should we intubate? J Thorac Dis (2013) 1.10
Clinical management of obese patients with cancer. Nat Rev Clin Oncol (2013) 1.06
Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg (2014) 0.87
Morbidities of lung cancer surgery in obese patients. J Thorac Cardiovasc Surg (2013) 0.84
Integrated Palliative Care and Oncologic Care in Non-Small-Cell Lung Cancer. Curr Treat Options Oncol (2016) 0.75
Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index. Ann Thorac Surg (2016) 0.75
Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study. J Cardiothorac Surg (2016) 0.75
The combined effect of age and body mass index on outcomes in foregut surgery: a regression model analysis of the National Surgical Quality Improvement Program data. Surg Endosc (2015) 0.75
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst (2003) 3.41
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med (2012) 3.27
Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A (2009) 3.10
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44
Predictors of prolonged air leak after pulmonary lobectomy. Ann Thorac Surg (2004) 2.40
Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer. J Clin Oncol (2011) 2.27
Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography. Ann Thorac Surg (2008) 2.14
Persistent air leak after pulmonary resection: the water-valve "foam" problem. Ann Thorac Surg (2004) 2.03
Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) (2011) 1.98
Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg (2011) 1.94
Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. J Thorac Cardiovasc Surg (2006) 1.93
Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg (2009) 1.91
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83
Efficacy and safety of TachoSil® versus standard treatment of air leakage after pulmonary lobectomy. Eur J Cardiothorac Surg (2010) 1.73
Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. Ann Thorac Surg (2007) 1.63
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study. J Clin Oncol (2010) 1.63
Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol (2009) 1.61
Anomalous segmental vein for right upper lobe: an unusual anatomical variation. Ann Thorac Surg (2002) 1.60
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. Lancet Oncol (2007) 1.60
Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria? Eur J Cardiothorac Surg (2011) 1.56
Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. Ann Thorac Surg (2007) 1.50
Hemodynamic instability during superior vena cava crossclamping: predictors, management, and clinical consequences. J Thorac Cardiovasc Surg (2007) 1.49
Computed tomography-guided preoperative radiotracer localization of nonpalpable lung nodules. Ann Thorac Surg (2010) 1.48
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare. J Clin Oncol (2004) 1.48
Evolution of emphysema in relation to smoking. Eur Radiol (2009) 1.47
Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group. Ann Surg Oncol (2002) 1.46
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer (2008) 1.45
Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg (2003) 1.40
Robotic anatomic segmentectomy of the lung: technical aspects and initial results. Ann Thorac Surg (2012) 1.26
Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer. Ann Thorac Surg (2005) 1.25
Resection for tumors with carinal involvement: technical aspects, results, and prognostic factors. Ann Thorac Surg (2005) 1.25
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer (2007) 1.21
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol (2014) 1.20
Stair climbing test predicts cardiopulmonary complications after lung resection. Chest (2002) 1.17
Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice. Oncology (2008) 1.17
Comparison of water seal and suction after pulmonary lobectomy: a prospective, randomized trial. Ann Thorac Surg (2004) 1.15
Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol (2009) 1.15
Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg (2008) 1.14
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations. J Thorac Oncol (2011) 1.14
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res (2013) 1.13
Solid-liquid iron partitioning in Earth's deep mantle. Nature (2012) 1.10
Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib. J Clin Oncol (2011) 1.09
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol (2002) 1.09
Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer (2007) 1.08
Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: an update. Clin Chem Lab Med (2007) 1.08
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.07
Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07
Pleomorphic carcinomas of the lung show a selective distribution of gene products involved in cell differentiation, cell cycle control, tumor growth, and tumor cell motility: a clinicopathologic and immunohistochemical study of 31 cases. Am J Surg Pathol (2003) 1.06
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases". J Thorac Oncol (2011) 1.06
Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila) (2010) 1.06
Self-collected human papillomavirus testing acceptability: comparison of two self-sampling modalities. J Womens Health (Larchmt) (2011) 1.04
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumors. PLoS One (2010) 1.04
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis. Lung Cancer (2010) 1.03
Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann Thorac Surg (2007) 1.03
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. Mod Pathol (2004) 1.01
Experience with robotic lobectomy for lung cancer. Innovations (Phila) (2011) 1.01
Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res (2004) 1.00
The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci (2004) 1.00
A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol (2006) 1.00